USPTO serial 79341895
SYMBIOZE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 27, 2024
- Examiner
- WERT, KARL ANTHONY
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SYMBIOZE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andy I. Corea
Andy I. Corea Murtha Cullina LLP265 Church StreetNew Haven, CT 06510-1220UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Injection devices for pharmaceutical preparations; injection pumps for pharmaceutical purposes; portable medical fluid injectors; medical and therapeutic apparatus and instruments for medication self-injection being medical infusion and injection devices for administering drugs; medical apparatus for intravenous, intradermal, intramuscular or subcutaneous infusion, tissue infusion, injection and accessories thereof being patch-worn on-body injector, namely, a syringe for medical purposes and consisting of disposable or reusable medical apparatus for intravenous, intradermal, intramuscular or subcutaneous medical infusion, medical tissue infusion, medical injection intended to cooperate with a medical pump, all the foregoing being medical infusion and injection devices for administering drugs; medical and therapeutic apparatus and instruments for medication self-injection being medical infusion and injection devices for administering drugs; medical adhesive apparatus for intravenous, intradermal, intramuscular or subcutaneous injection or infusion and replacement parts thereof being patch-worn on-body injector, namely, a syringe for medical purposes and consisting of disposable or reusable medical apparatus for intravenous, intradermal, intramuscular or subcutaneous medical infusion, medical tissue infusion, medical injection intended to cooperate with a medical pump, all the foregoing being medical infusion and injection devices for administering drugs; medical pumps for intravenous, intramuscular, intradermal or subcutaneous injection or infusion and replacement parts thereof, namely, reusable or disposable medical pump intended to cooperate with medical apparatus for intravenous, intradermal, intramuscular or subcutaneous medical infusion, medical tissue infusion, medical injection, all the foregoing being medical infusion or injection devices and replacement parts thereof for administering drugs; patch pumps being adhesive infusion pumps for delivering measured injection of pharmaceutical preparations into the bloodstream over time and replacement parts thereof, namely, reusable or disposable medical pump intended to cooperate with medical apparatus for intravenous, intradermal, intramuscular or subcutaneous medical infusion, medical tissue infusion, medical injection | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 11, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 27, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 8, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 8, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 28, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 28, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 27, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 27, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 12, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 12, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 11, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 27, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Nov 22, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 22, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 22, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 8, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 8, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 3, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 3, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 3, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 3, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 3, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 22, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 21, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 21, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 19, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 30, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 30, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 8, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 7, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 30, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 7, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 3, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 2, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |